MVA Members

Sygnature Discovery is a world-leading, integrated drug discovery CRO with operations in the UK and North America. With a team of over 1,000 professionals - including more than 900 scientists - we collaborate globally with biotech, pharma, and NFP organizations to accelerate the development of innovative therapeutics. Sygnature has a proven track record of success, having contributed to the delivery of 60+ novel preclinical and 35+ clinical compounds for our partners. Our scientists are named on over 235 patents, reflecting the impact and innovation we bring to each collaboration. Our comprehensive expertise spans medicinal chemistry, computational chemistry, protein science, in-vitro biology, DMPK, cellular pharmacology, in-vivo pharmacology, and formulation sciences. This multidisciplinary approach enables us to deliver high-quality, data-driven solutions across multiple modalities, therapeutic areas and throughout the entire drug discovery journey.